-
1
-
-
84880511470
-
Chronic kidney disease: Global dimension and perspectives
-
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: Global dimension and perspectives. Lancet 2013;382:260-72.
-
(2013)
Lancet
, vol.382
, pp. 260-272
-
-
Jha, V.1
Garcia-Garcia, G.2
Iseki, K.3
Li, Z.4
Naicker, S.5
Plattner, B.6
-
2
-
-
80054849522
-
Efficacy and safety of continuous erythropoietin receptor activator (CERA)
-
Aggawal HK, Jain D, Verma K. Efficacy and safety of continuous erythropoietin receptor activator (CERA). Int J Pharm Pharm Sci 2011;3:292-6.
-
(2011)
Int J Pharm Pharm Sci
, vol.3
, pp. 292-296
-
-
Aggawal, H.K.1
Jain, D.2
Verma, K.3
-
3
-
-
84872790690
-
Chronic kidney disease
-
Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors 18th ed. New York: The McGraw Hill Companies, Inc.
-
Bargman JM, Skorecki K. Chronic kidney disease. In Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's Principles of Internal Medicine. 18th ed. New York: The McGraw Hill Companies, Inc.; 2012.
-
(2012)
Harrison's Principles of Internal Medicine
-
-
Bargman, J.M.1
Skorecki, K.2
-
4
-
-
70549093829
-
Inflammation and its impact on anaemia in chronic kidney disease: From haemoglobin variability to hyporesponsiveness
-
De Francisco AL, Stenvinkel P, Vaulont S. Inflammation and its impact on anaemia in chronic kidney disease: From haemoglobin variability to hyporesponsiveness. NDT Plus 2009;2 Suppl 1:i18-26.
-
(2009)
NDT Plus
, vol.2
, pp. i18-26
-
-
De Francisco, A.L.1
Stenvinkel, P.2
Vaulont, S.3
-
5
-
-
0036174760
-
Clinical factors influencing sensitivity and response to epoetin
-
Richardson D. Clinical factors influencing sensitivity and response to epoetin. Nephrol Dial Transplant 2002;17 Suppl 1:53-9.
-
(2002)
Nephrol Dial Transplant
, vol.17
, pp. 53-59
-
-
Richardson, D.1
-
7
-
-
84861154879
-
Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: A cross-sectional study
-
Uehata T, Tomosugi N, Shoji T, Sakaguchi Y, Suzuki A, Kaneko T, et al. Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: A cross-sectional study. Nephrol Dial Transplant 2012;27:1076-83.
-
(2012)
Nephrol Dial Transplant
, vol.27
, pp. 1076-1083
-
-
Uehata, T.1
Tomosugi, N.2
Shoji, T.3
Sakaguchi, Y.4
Suzuki, A.5
Kaneko, T.6
-
9
-
-
10844258104
-
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
-
Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
-
(2004)
Science
, vol.306
, pp. 2090-2093
-
-
Nemeth, E.1
Tuttle, M.S.2
Powelson, J.3
Vaughn, M.B.4
Donovan, A.5
Ward, D.M.6
-
10
-
-
33846650973
-
Molecular control of iron transport
-
Ganz T. Molecular control of iron transport. J Am Soc Nephrol 2007;18:394-400.
-
(2007)
J Am Soc Nephrol
, vol.18
, pp. 394-400
-
-
Ganz, T.1
-
11
-
-
2342510407
-
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
-
Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6.
-
(2004)
J Clin Invest
, vol.113
, pp. 1271-1276
-
-
Nemeth, E.1
Rivera, S.2
Gabayan, V.3
Keller, C.4
Taudorf, S.5
Pedersen, B.K.6
-
12
-
-
0035896581
-
A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload
-
Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-9.
-
(2001)
J Biol Chem
, vol.276
, pp. 7811-7819
-
-
Pigeon, C.1
Ilyin, G.2
Courselaud, B.3
Leroyer, P.4
Turlin, B.5
Brissot, P.6
-
13
-
-
33845245942
-
Suppression of hepcidin during anemia requires erythropoietic activity
-
Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006;108:3730-5.
-
(2006)
Blood
, vol.108
, pp. 3730-3735
-
-
Pak, M.1
Lopez, M.A.2
Gabayan, V.3
Ganz, T.4
Rivera, S.5
-
14
-
-
84903609037
-
The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease
-
Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, et al. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease. PLoS One 2014;9:e99781.
-
(2014)
PLoS One
, vol.9
, pp. e99781
-
-
Mercadal, L.1
Metzger, M.2
Haymann, J.P.3
Thervet, E.4
Boffa, J.J.5
Flamant, M.6
-
15
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
National Kidney Foundation
-
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39 2 Suppl 1:S1-266.
-
(2002)
Am J Kidney Dis
, vol.39
, Issue.2
, pp. S1-266
-
-
-
16
-
-
84884333035
-
KDIGO clinical practice guideline for anemia in chronic kidney disease
-
Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group.
-
Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2012;2:279-335.
-
(2012)
Kidney Int Suppl
, vol.2
, pp. 279-335
-
-
-
17
-
-
33646345152
-
KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease
-
KDOQI; National Kidney Foundation
-
KDOQI; National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47 5 Suppl 3:S11-145.
-
(2006)
Am J Kidney Dis
, vol.47
, Issue.5
, pp. S11-145
-
-
-
18
-
-
77649206366
-
Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate
-
Peters HP, Laarakkers CM, Swinkels DW, Wetzels JF. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol Dial Transplant 2010;25:848-53.
-
(2010)
Nephrol Dial Transplant
, vol.25
, pp. 848-853
-
-
Peters, H.P.1
Laarakkers, C.M.2
Swinkels, D.W.3
Wetzels, J.F.4
-
19
-
-
64949191416
-
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
-
Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, et al. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 2009;75:976-81.
-
(2009)
Kidney Int
, vol.75
, pp. 976-981
-
-
Ashby, D.R.1
Gale, D.P.2
Busbridge, M.3
Murphy, K.G.4
Duncan, N.D.5
Cairns, T.D.6
-
20
-
-
69249208830
-
Hepcidin - A potential novel biomarker for iron status in chronic kidney disease
-
Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, et al. Hepcidin - A potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1051-6.
-
(2009)
Clin J Am Soc Nephrol
, vol.4
, pp. 1051-1056
-
-
Zaritsky, J.1
Young, B.2
Wang, H.J.3
Westerman, M.4
Olbina, G.5
Nemeth, E.6
-
22
-
-
73149122764
-
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: Need for standardization
-
Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: Need for standardization. Haematologica 2009;94:1748-52.
-
(2009)
Haematologica
, vol.94
, pp. 1748-1752
-
-
Kroot, J.J.1
Kemna, E.H.2
Bansal, S.S.3
Busbridge, M.4
Campostrini, N.5
Girelli, D.6
-
23
-
-
77957588960
-
Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients
-
Ford BA, Eby CS, Scott MG, Coyne DW. Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients. Kidney Int 2010;78:769-73.
-
(2010)
Kidney Int
, vol.78
, pp. 769-773
-
-
Ford, B.A.1
Eby, C.S.2
Scott, M.G.3
Coyne, D.W.4
|